Analyst recommendations for Albemarle
As of June 8, 2017, 19 brokerage firms were actively tracking Albemarle (ALB) stock. About 53.0% of them have recommended a “buy” for the stock, and 47.0% have recommended a “hold.” None of them have recommended a “sell.”
Analysts’ consensus suggests that Albemarle’s 12-month target price is $119.31, implying a return potential of 4.4% from its closing price of $114.27 as of June 8, 2017.
Why many analysts are recommending a ‘buy’ or ‘hold’
Albemarle’s better-than-expected 1Q17 earnings and an upward revision of its fiscal 2017 revenues and adjusted EPS (earnings per share) have caused many analysts to recommend a “buy” or a “hold” for ALB stock. Their recommendations were also affected by its revised fiscal 2017 revenue and adjusted EPS, driven by the increasing demand for lithium.
Target prices by individual brokers
Below are the recommended target prices for Albemarle from some of the brokerage firms:
- Nomura issued Albemarle a target price of $134, which implies a 12-month potential return of 17.3% over the closing price of $114.27 on June 8, 2017.
- Morgan Stanley (MS) rated Albemarle as “equal weight” with a target price of $100, which implies a 12-month potential return of -12.5% over the closing price of $114.27 on June 8, 2017.
- Deutsche Bank (DB) gave Albemarle a target price of $116, which implies a 12-month potential return of 1.5% over the closing price of $114.27 as of June 8, 2017.
You can indirectly hold Albemarle by investing in the PowerShares WilderHill Progressive Energy ETF (PUW), which has invested 2.7% in Albemarle as of June 8, 2017. The top holdings of the fund include FMC (FMC) with a weight of 3.1%.